Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Papillomavirus Infections × Delivery of Health Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 28 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 19 Papillomavirus Vaccines 9 Radiotherapy, Intensity-Modulated 4 Cisplatin 4 fludarabine 3 Vaccines, Synthetic 3 Engerix-B 3 Cyclophosphamide 3 Blood Specimen Collection 3 halofantrine 2 fludarabine phosphate 2 aldesleukin 2 Watchful Waiting 2 Vaccines 2 Paclitaxel 2 Light Coagulation 2 Interleukin-2 2 Imiquimod 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Hepatitis A Vaccines 2 Fluorouracil 2 Electrocoagulation 2 Cetuximab 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 utomilumab 1 polyphenon E 1 infigratinib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04660331 2024-10-09

PROMOTE

Fred Hutchinson Cancer Center

Phase NA Completed

42 enrolled 14 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡